NDLEA MMIA Strategic Command seizes 9 tonnes of illicit drugs
Lagos, June 2026 (TBL Africa) The National Drug Law Enforcement Agency (NDLEA), Murtala Muhammad International Airport Strategic Command, Ikeja, seized 9,058. 543kg of illicit drugs from 2025 to June 26, 2026.
The command also arrested 260 suspects and successfully prosecuted and secured conviction of 101 offenders during the period.
The Commander, Mr Mohammad Ahmad, made the disclosure on Friday during the command’s commemoration of the International Day Against Drug Abuse and Illicit Trafficking.
The event had the theme, “World Drug Problem: Persisting Issues, New Challenges, Innovative Responses”.
Ahmad said that the command had continued to achieve significant successes through innovative drug law enforcement strategies.
He said the achievements underscored the command’s commitment to safeguarding the nation from the menace of drug abuse and trafficking.
He called for sustained collaboration among government agencies, communities and other stakeholders to tackle challenges posed by drug trafficking.
In her remarks, retired Assistant Commander-General of Narcotics Ibiba Odili urged Nigerians to support anti-drug campaigns.
Odili said that collective action remained essential in addressing the growing threat of substance abuse and drug trafficking.
One of the participants, Chibuzor Osakwe, stressed the importance of continuous public enlightenment on the dangers of drug abuse and trafficking.
She said that the youth, particularly, would need to understand the consequences of illicit drug use and the need to make healthy and responsible life choices.
The News Agency of Nigeria (NAN) reports that International Day Against Drug Abuse and Illicit Trafficking has been observed annually on June 26 since 1989.
It is aimed by the United Nations to raise awareness against drug abuse and illegal drug trade.
The 2026 edition seeks to strengthen global cooperation in preventing drug abuse, combating drug trafficking and promoting effective and innovative responses to emerging drug-related challenges
